30 patents
Page 2 of 2
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
30 Mar 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 1 Aug 17
Utility
Spiro-lactam Nmda Receptor Modulators and Uses Thereof
18 Feb 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 31 Jan 19
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
16 Feb 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 1 Aug 17
Utility
Spiro-lactam Nmda Receptor Modulators and Uses Thereof
11 Feb 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 31 Jan 19
Utility
Spiro-lactam Nmda Modulators and Methods of Using Same
6 Jan 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 3 Feb 20
Utility
Spiro-lactam Nmda Receptor Modulators and Uses Thereof
1 Jul 20
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity.
John A. Lowe, III, M. Amin Khan
Filed: 8 Aug 19
Utility
Spiro-lactam and Bis-spiro-lactam Nmda Receptor Modulators and Uses Thereof
10 Jun 20
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 31 Jul 17
Utility
Spiro-lactam Nmda Modulators and Methods of Using Same
30 Oct 19
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 20 Nov 18
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
14 Oct 19
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity.
John A. Lowe, III, M. Amin Khan
Filed: 1 May 18
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
14 Oct 19
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity.
John A. Lowe, III, M. Amin Khan
Filed: 1 May 18